阿尔茨海默病前期主观认知能力下降的检测与干预

雅红 何
{"title":"阿尔茨海默病前期主观认知能力下降的检测与干预","authors":"雅红 何","doi":"10.12677/ijpn.2022.114010","DOIUrl":null,"url":null,"abstract":"Alzheimer’s disease (Alzheimer’s disease, AD) is common in the elderly neurodegenerative diseases, and is an irreversible disease. As with other neurodegenerative diseases, AD lacks any effective treatment. Although there has been a lot of research on AD in recent years, it is a pity that so far no drug has been developed that can completely treat AD. AD is one of the most important diseases that cause death in the elderly today. Therefore, it is particularly important to diagnose and intervene in the early stage of AD, and to detect and intervene as early as possible. Subjective cognitive decline (SCD) is the first clinical manifestation in the AD continuum, and it is also the preclinical stage of AD, mainly manifested by individuals who feel a continuous decline in their cognitive function, while the cognitive evaluation shows normal. Studies have found that SCD is associated with AD biomarkers: structural and functional changes on magnetic resonance and positron emission tomography images, resulting in an increased risk of mild cognitive impairment and dementia in individuals with SCD. An association between higher education and intellectual activity levels and better cognitive performance later in life was found. Therefore, in the early stage, diagnostic identification of SCD can reduce the risk of developing AD. Using “Subjective cognitive decline” as the keyword, searching for the database, judging by the diagnostic predictors of SCD, preventing or reducing these diagnostic predictors through drug intervention and non-drug intervention of SCD can effectively reduce the occurrence of SCD to a certain extent, and then reduce the likelihood of developing AD. It is also found that there is still a controversy in both the prediction of the detection and the intervention, and more research is needed to confirm the correct statement. In conclusion, performing the detection and intervention of SCD early on has the potential to reduce the occurrence of AD.","PeriodicalId":398696,"journal":{"name":"International Journal of Psychiatry and Neurology","volume":"71 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Detection and Intervention of Subjective Cognitive Decline in Pre-Alzheimer’s Disease\",\"authors\":\"雅红 何\",\"doi\":\"10.12677/ijpn.2022.114010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Alzheimer’s disease (Alzheimer’s disease, AD) is common in the elderly neurodegenerative diseases, and is an irreversible disease. As with other neurodegenerative diseases, AD lacks any effective treatment. Although there has been a lot of research on AD in recent years, it is a pity that so far no drug has been developed that can completely treat AD. AD is one of the most important diseases that cause death in the elderly today. Therefore, it is particularly important to diagnose and intervene in the early stage of AD, and to detect and intervene as early as possible. Subjective cognitive decline (SCD) is the first clinical manifestation in the AD continuum, and it is also the preclinical stage of AD, mainly manifested by individuals who feel a continuous decline in their cognitive function, while the cognitive evaluation shows normal. Studies have found that SCD is associated with AD biomarkers: structural and functional changes on magnetic resonance and positron emission tomography images, resulting in an increased risk of mild cognitive impairment and dementia in individuals with SCD. An association between higher education and intellectual activity levels and better cognitive performance later in life was found. Therefore, in the early stage, diagnostic identification of SCD can reduce the risk of developing AD. Using “Subjective cognitive decline” as the keyword, searching for the database, judging by the diagnostic predictors of SCD, preventing or reducing these diagnostic predictors through drug intervention and non-drug intervention of SCD can effectively reduce the occurrence of SCD to a certain extent, and then reduce the likelihood of developing AD. It is also found that there is still a controversy in both the prediction of the detection and the intervention, and more research is needed to confirm the correct statement. In conclusion, performing the detection and intervention of SCD early on has the potential to reduce the occurrence of AD.\",\"PeriodicalId\":398696,\"journal\":{\"name\":\"International Journal of Psychiatry and Neurology\",\"volume\":\"71 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Psychiatry and Neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12677/ijpn.2022.114010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Psychiatry and Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12677/ijpn.2022.114010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Detection and Intervention of Subjective Cognitive Decline in Pre-Alzheimer’s Disease
Alzheimer’s disease (Alzheimer’s disease, AD) is common in the elderly neurodegenerative diseases, and is an irreversible disease. As with other neurodegenerative diseases, AD lacks any effective treatment. Although there has been a lot of research on AD in recent years, it is a pity that so far no drug has been developed that can completely treat AD. AD is one of the most important diseases that cause death in the elderly today. Therefore, it is particularly important to diagnose and intervene in the early stage of AD, and to detect and intervene as early as possible. Subjective cognitive decline (SCD) is the first clinical manifestation in the AD continuum, and it is also the preclinical stage of AD, mainly manifested by individuals who feel a continuous decline in their cognitive function, while the cognitive evaluation shows normal. Studies have found that SCD is associated with AD biomarkers: structural and functional changes on magnetic resonance and positron emission tomography images, resulting in an increased risk of mild cognitive impairment and dementia in individuals with SCD. An association between higher education and intellectual activity levels and better cognitive performance later in life was found. Therefore, in the early stage, diagnostic identification of SCD can reduce the risk of developing AD. Using “Subjective cognitive decline” as the keyword, searching for the database, judging by the diagnostic predictors of SCD, preventing or reducing these diagnostic predictors through drug intervention and non-drug intervention of SCD can effectively reduce the occurrence of SCD to a certain extent, and then reduce the likelihood of developing AD. It is also found that there is still a controversy in both the prediction of the detection and the intervention, and more research is needed to confirm the correct statement. In conclusion, performing the detection and intervention of SCD early on has the potential to reduce the occurrence of AD.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信